LCMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike
    1. Databases

    1. Industries

    1. Instrumentation

    1. Manufacturer

    1. Author

    1. Content Type

    1. Publication Date

    Applications from the field of Pharma & Biopharma focused on Software | LabRulez LCMS

    Data Integrity in Pharmaceutical Quality Control Laboratories: What You Need to Know

    Technical notes
    | 2016 | Agilent Technologies
    Software
    Instrumentation
    Software
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Meeting Regulatory Compliance Guidelines with Agilent ICP-MS MassHunter and OpenLab Server or ECM XT

    Technical notes
    | 2021 | Agilent Technologies
    Software, ICP/MS
    Instrumentation
    Software, ICP/MS
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent ICP Expert 21 CFR Part 11 software

    Technical notes
    | 2020 | Agilent Technologies
    Software, ICP/OES
    Instrumentation
    Software, ICP/OES
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Meeting Regulatory Compliance Guidelines with Agilent ICP-MS MassHunter and OpenLab Enterprise Content Manager (ECM)

    Technical notes
    | 2021 | Agilent Technologies
    Software, ICP/MS
    Instrumentation
    Software, ICP/MS
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    USP <232>/<233> and ICH Q3D Elemental Impurities Analysis: The Agilent ICP-MS Solution

    Technical notes
    | 2021 | Agilent Technologies
    Software, HPLC, ICP/MS, Speciation analysis
    Instrumentation
    Software, HPLC, ICP/MS, Speciation analysis
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    USP <232>/<233> and ICH Q3D Elemental Impurities Analysis: The Agilent ICP-OES Solution

    Technical notes
    | 2021 | Agilent Technologies
    Software, ICP/OES
    Instrumentation
    Software, ICP/OES
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent MicroLab Pharma

    Technical notes
    | 2020 | Agilent Technologies
    Software, FTIR Spectroscopy
    Instrumentation
    Software, FTIR Spectroscopy
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent Cary WinUV Pharma

    Technical notes
    | 2016 | Agilent Technologies
    Software, UV–VIS spectrophotometry
    Instrumentation
    Software, UV–VIS spectrophotometry
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent Cary UV Workstation Software for Cary 3500

    Technical notes
    | 2021 | Agilent Technologies
    Software, UV–VIS spectrophotometry
    Instrumentation
    Software, UV–VIS spectrophotometry
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Pharmaceutical Analysis using UV-Vis: Compliance with Supplement I to the Japanese Pharmacopoeia 18th Ed., Section 2.24

    Technical notes
    | 2021 | Agilent Technologies
    Software, UV–VIS spectrophotometry
    Instrumentation
    Software, UV–VIS spectrophotometry
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma
     

    Related content


    Introducing the Mnova Purification Suite: your solution for streamlined chromatography purifications!

    Mo, 8.4.2024
    Mestrelab Research

    TRIO OF UTA CHEMISTS RECOGNIZED AS LEADING LIGHTS

    Th, 2.5.2024
    The University of Texas at Arlington

    “Fat can be extracted even from thousand-year-old pottery,” says V. Brychová

    We, 1.5.2024
    Akademie věd České republiky
    Other projects
    Follow us
    More information
    WebinarsAbout usContact usTerms of use
    LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike